Clinical Trial: A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a ...
The VALOR study investigates Lacosamide's efficacy in reducing seizures in patients with idiopathic generalized epilepsy, already on anti-epileptic drugs. Enrolling children and adults from age 4, with at least 2 seizures in the past 12 weeks, in 23 countries. Patients have a 50% chance of receiving placebo, with an option for Lacosamide in an open-label extension.
Reference News
Clinical Trial: A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a ...
The VALOR study investigates Lacosamide's efficacy in reducing seizures in patients with idiopathic generalized epilepsy, already on anti-epileptic drugs. Enrolling children and adults from age 4, with at least 2 seizures in the past 12 weeks, in 23 countries. Patients have a 50% chance of receiving placebo, with an option for Lacosamide in an open-label extension.